Long term complications and prognostic factors in locally advanced nasopharyngeal carcinoma treated with docetaxel, cisplatin, 5-fluorouracil induction chemotherapy followed by concurrent chemoradiotherapy: A retrospective cohort study

Documenti analoghi

• Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
  di: Zeng, Zhen, et al.
  Pubblicazione: (2018)
• Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil
  di: Tamaki, Yukihisa, et al.
  Pubblicazione: (2018)
• The Efficacy of an Induction Chemotherapy Combination with Docetaxel, Cisplatin, and 5-FU Followed by Concurrent Chemoradiotherapy in Advanced Head and Neck Cancer
  di: Ahn, Jae-Sook, et al.
  Pubblicazione: (2007)
• Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinoma
  di: Fangzheng, Wang, et al.
  Pubblicazione: (2017)
• Concurrent chemoradiotherapy with intravenous cisplatin and docetaxel for advanced oral cancer
  di: Sato, Kotaro, et al.
  Pubblicazione: (2019)